Sutro Biopharma, Inc. - Common Stock (NQ:STRO)

10.52 -0.49 (-4.45%)

Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sutro Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >

The market is filled with gapping stocks in Wednesday's session. ↗

August 12, 2026

Via Chartmill

Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million ↗

May 31, 2026

Mineralys Therapeutics develops novel therapies for resistant hypertension, with its lead candidate advancing through clinical trials.

Via The Motley Fool

Topics Regulatory Compliance

Top movers in Monday's pre-market session ↗

December 01, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Expert Outlook: Sutro Biopharma Through The Eyes Of 6 Analysts ↗

December 11, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Sutro Biopharma Through 5 Analysts ↗

November 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 22, 2025

Via Benzinga

Top stock movements in today's session. ↗

October 17, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 20, 2025

Via Benzinga

Sutro Biopharma Inc (NASDAQ:STRO) Reports Q2 2025 Revenue Beat and Narrower Losses, Shares Rise in After-Hours Trading ↗

August 07, 2025

Sutro Biopharma (STRO) reported strong Q2 2025 results, beating revenue estimates with $63.75M and narrowing losses. Shares rose as pipeline progress, including STRO-004's H2 2025 trial, boosted...

Via Chartmill

Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews ↗

April 29, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

April 25, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Top stock movements in today's session. ↗

April 25, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 25, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

April 25, 2025

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Which stocks are experiencing notable movement on Tuesday? ↗

April 22, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are moving on Monday? ↗

April 07, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

April 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 07, 2025

Via Benzinga

This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

March 17, 2025

Via Benzinga

Wall Street's Top 10 Stock Calls This Week - Saturday, March 15 ↗

March 15, 2025

What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of March 10-14, 2025.

Via Talk Markets

Topics Stocks / Equities

Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session. ↗

March 14, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Which stocks are experiencing notable movement on Friday? ↗

March 14, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 14, 2025

Via Benzinga

Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline ↗

March 14, 2025

Sutro Biopharma reported $62 million in 2024 revenue, down from $153.7 million in 2023, and announced a pipeline restructuring.

Via Benzinga

Dow Jumps Over 600 Points; US Consumer Sentiment Tumbles In March ↗

March 14, 2025

Via Benzinga

Topics Stocks

Nasdaq Surges 1.5%; Ulta Beauty Posts Upbeat Results ↗

March 14, 2025

Via Benzinga

This T-Mobile Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday ↗

March 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 07, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.